CVS Eyes Carbon as Tech Partner
Carbon Health
The real upside in the CVS relationship is that Carbon can matter to a much larger footprint than its own clinics. Carbon built CarbyOS to run scheduling, charting, billing, follow ups, and AI note taking in one workflow, and CVS has both capital and a giant care delivery base that needs modernization across MinuteClinic, Oak Street Health, and broader care operations. That makes Carbon potentially more useful to CVS as software and workflow infrastructure than as another clinic brand.
-
CVS signaled strategic interest by leading Carbon’s January 2023 Series D with $100M, with the raise earmarked for expanding care delivery, value based arrangements, and technology. That is the profile of an investor looking for operating leverage, not just financial exposure to another urgent care chain.
-
Carbon’s product is unusually exportable for a provider. Its app, EHR, ambient scribing, billing, and care coordination tools already sit on one stack, and Carbon has pointed to CVS piloting its technology inside stores. If that works, Carbon can grow through partner locations without signing more leases or staffing every site itself.
-
The Walgreens and VillageMD outcome shows why this matters. Large retail clinic rollouts can create huge revenue, but they are hard to make profitable, and Walgreens has taken repeated VillageMD impairment charges while weighing sale and restructuring options. For CVS, buying software that improves throughput can be safer than copying Carbon’s clinic model store by store.
The next phase is whether retail healthcare buyers treat clinic operators as vendors instead of rivals. If CVS deepens use of Carbon’s software, Carbon’s best path becomes infrastructure, where its own clinics serve as test sites and larger partners provide the scale. That would shift the business from local clinic density toward higher margin workflow and operating system revenue.